Annual Current Liabilities
$3.83 M
+$1.09 M+39.81%
June 1, 2024
Summary
- As of February 24, 2025, NEUP annual total current liabilities is $3.83 million, with the most recent change of +$1.09 million (+39.81%) on June 1, 2024.
- During the last 3 years, NEUP annual current liabilities has risen by +$2.06 million (+115.89%).
Performance
NEUP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$2.13 M
-$418.00 K-16.38%
December 1, 2024
Summary
- As of February 24, 2025, NEUP quarterly total current liabilities is $2.13 million, with the most recent change of -$418.00 thousand (-16.38%) on December 1, 2024.
- Over the past year, NEUP quarterly current liabilities has stayed the same.
Performance
NEUP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NEUP Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.8% | 0.0% |
| 3 y3 years | +115.9% | - |
| 5 y5 years | -60.4% | -80.4% |
NEUP Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -53.7% | -44.3% | at low |
| 5 y | 5-year | -60.4% | -53.7% | -80.4% | -16.9% |
| alltime | all time | -64.1% | -97.3% | -80.4% | -94.1% |
Neuphoria Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $2.13 M(-16.4%) |
| Sep 2024 | - | $2.55 M(-33.4%) |
| Jun 2024 | - | $3.83 M(+27.1%) |
| Jun 2024 | $3.83 M(+39.8%) | - |
| Dec 2023 | - | $3.01 M(+10.0%) |
| Jun 2023 | $2.74 M(+18.6%) | $2.74 M(+9.9%) |
| Dec 2022 | - | $2.49 M(+7.9%) |
| Jun 2022 | $2.31 M(+30.2%) | $2.31 M(-3.9%) |
| Dec 2021 | - | $2.40 M(+35.4%) |
| Jun 2021 | $1.77 M(-68.8%) | $1.77 M(-74.6%) |
| Dec 2020 | - | $6.98 M(+22.8%) |
| Jun 2020 | $5.68 M(-41.2%) | $5.68 M(-47.7%) |
| Dec 2019 | - | $10.88 M(+12.5%) |
| Jun 2019 | $9.67 M(-0.9%) | $9.67 M(+2.7%) |
| Dec 2018 | - | $9.42 M(-3.5%) |
| Jun 2018 | $9.76 M(-8.6%) | $9.76 M(+66.9%) |
| Dec 2017 | - | $5.85 M(-45.2%) |
| Jun 2017 | $10.67 M(+25.5%) | $10.67 M(+17.7%) |
| Dec 2016 | - | $9.07 M(+6.6%) |
| Jun 2016 | $8.50 M(-19.1%) | $8.50 M(-20.0%) |
| Dec 2015 | - | $10.63 M(+1.1%) |
| Jun 2015 | $10.51 M(+20.3%) | $10.51 M(+56.9%) |
| Dec 2014 | - | $6.70 M(-23.3%) |
| Jun 2014 | $8.74 M(+57.4%) | $8.74 M(+81.9%) |
| Dec 2013 | - | $4.80 M(-13.5%) |
| Jun 2013 | $5.55 M | $5.55 M(+39.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $3.99 M(-12.8%) |
| Jun 2012 | $4.57 M(-21.9%) | $4.57 M(+57.6%) |
| Dec 2011 | - | $2.90 M(-50.4%) |
| Jun 2011 | $5.86 M(+113.0%) | $5.86 M(+88.5%) |
| Dec 2010 | - | $3.11 M(+13.0%) |
| Jun 2010 | $2.75 M(+22.1%) | $2.75 M(+31.7%) |
| Dec 2009 | - | $2.09 M(-7.3%) |
| Jun 2009 | $2.25 M(-22.8%) | $2.25 M(+1.5%) |
| Dec 2008 | - | $2.22 M(-24.0%) |
| Jun 2008 | $2.92 M(-4.8%) | $2.92 M(+16.9%) |
| Dec 2007 | - | $2.50 M(-18.5%) |
| Jun 2007 | $3.06 M(+54.0%) | $3.06 M(+48.9%) |
| Dec 2006 | - | $2.06 M(+3.4%) |
| Jun 2006 | $1.99 M(+28.2%) | $1.99 M(+25.5%) |
| Dec 2005 | - | $1.59 M(+2.1%) |
| Jun 2005 | $1.55 M(+58.0%) | $1.55 M(+13.0%) |
| Dec 2004 | - | $1.37 M(+39.8%) |
| Jun 2004 | $982.40 K(+18.5%) | $982.40 K(-26.1%) |
| Dec 2003 | - | $1.33 M(+60.4%) |
| Jun 2003 | $828.80 K(+74.7%) | $828.80 K(+17.6%) |
| Dec 2002 | - | $705.00 K(+48.6%) |
| Jun 2002 | $474.50 K(+57.0%) | $474.50 K(+45.2%) |
| Dec 2001 | - | $326.70 K(+8.1%) |
| Jun 2001 | $302.30 K(+191.5%) | $302.30 K(+140.1%) |
| Dec 2000 | - | $125.90 K |
| Jun 2000 | $103.70 K(-78.1%) | - |
| Jun 1999 | $472.60 K | - |
FAQ
- What is Neuphoria Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics annual current liabilities year-on-year change?
- What is Neuphoria Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics quarterly current liabilities year-on-year change?
What is Neuphoria Therapeutics annual total current liabilities?
The current annual current liabilities of NEUP is $3.83 M
What is the all time high annual current liabilities for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high annual total current liabilities is $10.67 M
What is Neuphoria Therapeutics annual current liabilities year-on-year change?
Over the past year, NEUP annual total current liabilities has changed by +$1.09 M (+39.81%)
What is Neuphoria Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of NEUP is $2.13 M
What is the all time high quarterly current liabilities for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high quarterly total current liabilities is $10.88 M
What is Neuphoria Therapeutics quarterly current liabilities year-on-year change?
Over the past year, NEUP quarterly total current liabilities has changed by $0.00 (0.00%)